Prognostic Factors for Soft Tissue Sarcomas
Author Information
Author(s): A. Ravaud, N.B. Buil, J.M. Coindre, P. Lagarde, P. Tramond, F. Bonichon, E. Stockle, G. Kantor, M. Trojani, J. Chauvergnel, D. Maree
Primary Institution: Fondation Bergonie, Comprehensive Cancer Centre, Bordeaux, France
Hypothesis
Can prognostic variables help select patients with operable soft tissue sarcomas for adjuvant chemotherapy trials?
Conclusion
Tumour grade and depth are significant prognostic factors for overall and metastasis-free survival in patients with operable soft tissue sarcomas.
Supporting Evidence
- Patients with grade 1 tumors had a 5-year overall survival rate of 97.8%.
- Patients with deep grade 3 tumors had a 5-year overall survival rate of 31.7%.
- Overall survival was significantly better in patients with limb primaries compared to non-limb tumors (P = 0.05).
- Patients with tumors less than 5 cm had significantly better overall survival (P = 0.01).
- Patients with invasion of neurovascular structures had significantly worse overall survival (P = 0.003).
Takeaway
Doctors can use certain characteristics of tumors to figure out which patients might need extra treatment after surgery for soft tissue sarcomas.
Methodology
The study analyzed 141 patients with non-metastatic soft tissue sarcoma treated with surgery and radiotherapy, evaluating prognostic variables through univariate and multivariate analyses.
Potential Biases
Potential bias due to the retrospective nature of the study and the exclusion of certain patient groups.
Limitations
The study only included patients treated at a single institution and excluded those who received preoperative or adjuvant chemotherapy.
Participant Demographics
77 males and 64 females, aged 16 to 87 with a median age of 50.3 years.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website